CUSIP: 87424L108
Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,930,988
-
Share change
-
+20,930,988
-
Total reported value
-
$268,953,000
-
Price per share
-
$12.85
-
Number of holders
-
45
-
Value change
-
+$268,953,000
-
Number of buys
-
45
Quarterly Holders Quick Answers
What is CUSIP 87424L108?
CUSIP 87424L108 identifies TLIS - TALIS BIOMEDICAL CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87424L108:
Institutional Holders of TALIS BIOMEDICAL CORP - COM (TLIS) as of Q1 2021
As of 31 Mar 2021,
TALIS BIOMEDICAL CORP - COM (TLIS) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,930,988 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, BOXER CAPITAL, LLC, Nicholas Investment Partners, LP, FEDERATED HERMES, INC., BlackRock Inc., Sectoral Asset Management Inc, Redmile Group, LLC, VANGUARD GROUP INC, and PERCEPTIVE ADVISORS LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.